These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Concurrent paclitaxel and radiation therapy in the treatment of solid tumors. Choy H Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):1-3. PubMed ID: 10210534 [No Abstract] [Full Text] [Related]
12. [Combined curietherapy and chemotherapy]. Mazeron JJ Cancer Radiother; 1998 Dec; 2(6):781-2. PubMed ID: 9922788 [No Abstract] [Full Text] [Related]
13. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers. Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432 [TBL] [Abstract][Full Text] [Related]
14. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers. Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682 [TBL] [Abstract][Full Text] [Related]
15. [Clinical experiences with the use of metronidazole in the radiotherapy of cancer patients]. Cyb AF; Chmelevskaja ZI; Kudrjavceva GT Radiobiol Radiother (Berl); 1985; 26(3):339-42. PubMed ID: 4059519 [No Abstract] [Full Text] [Related]
16. International Clinical Trials in Radiation Oncology. Chemical modifiers. Bartelink H; Bleehen NM; Phillips TL Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481 [No Abstract] [Full Text] [Related]
17. Modification of radiosensitivity following chemotherapy exposure: potential implications for combined-modality therapy. Britten RA Cancer Treat Res; 2002; 112():285-303. PubMed ID: 12481721 [No Abstract] [Full Text] [Related]
18. Clinical radiosensitization: why it does and does not work. Coleman CN; Mitchell JB J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210 [No Abstract] [Full Text] [Related]
19. Polymer-conjugated paclitaxel as a radiosensitizing agent--a big step forward for combined modality therapy? Tishler RB Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):563-4. PubMed ID: 12573741 [No Abstract] [Full Text] [Related]
20. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine. Epstein AH; Cook JA; Goffman T; Glatstein E BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703 [No Abstract] [Full Text] [Related] [Next] [New Search]